Thompson Elizabeth H.Z. has filed 17 insider transactions across 2 companies since March 2024.
Most recent transaction: a sale of 3435 shares of ACADIA PHARMACEUTICALS INC ($ACAD) on March 25, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | S | Common Stock | 3435 | $21.47 | 3,280.0000 | 170,650,000 | 51.15% | 0.00% |
| March 24, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | M | Common Stock | 6715 | $0.00 | 6,715.0000 | 170,650,000 | 9999.99% | 0.00% |
| March 24, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | M | Restricted Stock Units | 6715 | $0.00 | 20,146.0000 | 170,650,000 | 25.00% | 0.00% |
| March 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | A | Stock Option (Right to Buy) | 101574 | $0.00 | 101,574.0000 | 170,650,000 | 9999.99% | 0.06% |
| March 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | A | Restricted Stock Units | 29548 | $0.00 | 29,548.0000 | 170,650,000 | 9999.99% | 0.02% |
| Aug. 14, 2025 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | D | Common Stock | 7196 | $0.00 | 0.0000 | 61,816,099 | 100.00% | 0.01% |
| June 30, 2025 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | A | Common Stock | 694 | $0.00 | 7,196.0000 | 60,514,546 | 10.67% | 0.00% |
| March 31, 2025 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | A | Common Stock | 694 | $0.00 | 6,502.0000 | 60,514,546 | 11.95% | 0.00% |
| March 24, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | A | Stock Option (Right to Buy) | 91395 | $0.00 | 91,395.0000 | 166,362,000 | 9999.99% | 0.05% |
| March 24, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | A | Restricted Stock Units | 26861 | $0.00 | 26,861.0000 | 166,362,000 | 9999.99% | 0.02% |
| Dec. 31, 2024 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | A | Common Stock | 1452 | $0.00 | 5,808.0000 | 60,434,161 | 33.33% | 0.00% |
| Sept. 30, 2024 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | A | Common Stock | 1452 | $0.00 | 4,356.0000 | 60,434,161 | 50.00% | 0.00% |
| Aug. 12, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | A | Restricted Stock Units | 64544 | $0.00 | 64,544.0000 | 163,819,000 | 9999.99% | 0.04% |
| Aug. 12, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | A | Stock Option (Right to Buy) | 324582 | $0.00 | 324,582.0000 | 163,819,000 | 9999.99% | 0.20% |
| June 28, 2024 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | A | Common Stock | 1452 | $0.00 | 2,904.0000 | 52,311,958 | 100.00% | 0.00% |
| March 29, 2024 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | A | Common Stock | 1452 | $0.00 | 1,452.0000 | 52,311,958 | 9999.99% | 0.00% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | Thompson Elizabeth H.Z. | Not found | A | Stock Option (right to buy) | 29400 | $0.00 | 29,400.0000 | 52,311,958 | 9999.99% | 0.06% |